Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New sensor aims to reduce false alarms in IV monitoring

NCT ID NCT07228416

Knowledge-focused Sponsor: ivWatch, LLC Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 18, 2026 · Updated 2 times

Summary

This study will test a device called the ivWatch Model 400 on 25 healthy adults to see how often it gives false alarms when no IV problem exists. The sensor monitors common IV sites and alerts nurses if it thinks an infiltration (fluid leaking into tissue) may be happening. By checking normal, healthy tissues, researchers hope to improve the device's accuracy and reduce unnecessary checks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

20 people

The number who actually took part.

Started

Feb 2026

Finished

Feb 2026

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 18 years of age or older * Healthy individual, verified by an eligible designation on the Health History Form Exclusion Criteria: * Currently enrolled in another clinical trial * Currently pregnant or trying to become pregnant * Serious and uncontrolled medical condition * Tattoo(s), scarring, or bruising that severely limits vein visualization at a sensor monitoring location * Medical adhesive allergy * Sleepwalking occurrence in the last year * Current drug/alcohol dependence * Sick or had an infection in the last 14 days * Hospitalized in the last 14 days * Fever at the time of study visit (≥100.4°F)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Infiltration of peripheral iv therapy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Infiltration of peripheral iv therapy

Contacts and locations

Locations

  • ivWatch LLC

    Newport News, Virginia, 23606, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.